Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

616453 TGF-β RI Kinase Inhibitor III - CAS 356559-13-2 - Calbiochem

616453
Purchase on Sigma-Aldrich

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
356559-13-2C₂₀H₂₁N₃O₂ • HCl

Products

Catalogue NumberPackaging Qty/Pack
616453-2MG Plastic ampoule 2 mg
Description
OverviewA cell-permeable imidazolyl-pyridine compound that acts as a potent, ATP-competitive, reversible, and selective inhibitor of activin receptor-like kinase 4 (IC50 = 129 nM), 5 ( IC50 = 47 nM), and 7. It inhibits p38 MAPKα only at much higher concentrations (IC50 = 10.6 µM) and has little effect against ALK1/2/3/6 as well as a panel of 26 other kinases.
Catalogue Number616453
Brand Family Calbiochem®
SynonymsTransforming Growth Factor-β Type I Receptor Kinase Inhibitor III, 2-(5-Benzo[1,3]dioxol-4-yl-2-tert-butyl-1H-imidazol-4-yl)-6-methylpyridine, HCl, ALK5 Inhibitor III, SB-505124, HCl
References
ReferencesHu, T., et al. 2005. Am. J. Physiol. Renal Physiol. 289, F816.
DaCosta Byfield, S., et al. 2004. Mol. Pharmacol. 65, 744.
Product Information
CAS number356559-13-2
ATP CompetitiveY
FormLight yellow solid
Hill FormulaC₂₀H₂₁N₃O₂ • HCl
Chemical formulaC₂₀H₂₁N₃O₂ • HCl
Hygroscopic Hygroscopic
ReversibleY
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetActivin receptor-like kinase 4, 5, 7
Primary Target IC<sub>50</sub>129 nM, 47 nM, against activin receptor-like kinase 4, 5, respectively
Purity≥97% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Irritant
Storage +2°C to +8°C
Protect from Light Protect from light
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
616453-2MG 04055977185843

Documentation

TGF-β RI Kinase Inhibitor III - CAS 356559-13-2 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

TGF-β RI Kinase Inhibitor III - CAS 356559-13-2 - Calbiochem Certificates of Analysis

TitleLot Number
616453

References

Reference overview
Hu, T., et al. 2005. Am. J. Physiol. Renal Physiol. 289, F816.
DaCosta Byfield, S., et al. 2004. Mol. Pharmacol. 65, 744.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision13-September-2008 RFH
SynonymsTransforming Growth Factor-β Type I Receptor Kinase Inhibitor III, 2-(5-Benzo[1,3]dioxol-4-yl-2-tert-butyl-1H-imidazol-4-yl)-6-methylpyridine, HCl, ALK5 Inhibitor III, SB-505124, HCl
DescriptionA cell-permeable imidazolyl-pyridine compound that acts as a potent, ATP-competitive, reversible, and selective inhibitor of activin receptor-like kinase 4 (IC50 = 129 nM), 5 ( IC50 = 47 nM), and 7. It inhibits p38 MAPKα only at much higher concentrations (IC50 = 10.6 µM) and has little effect against ALK1/2/3/6 as well as a panel of 26 other kinases.
FormLight yellow solid
Intert gas (Yes/No) Packaged under inert gas
CAS number356559-13-2
Chemical formulaC₂₀H₂₁N₃O₂ • HCl
Structure formulaStructure formula
Purity≥97% by HPLC
SolubilityDMSO (20 mg/ml) or H₂O (3 mg/ml)
Storage Protect from light
+2°C to +8°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Irritant
ReferencesHu, T., et al. 2005. Am. J. Physiol. Renal Physiol. 289, F816.
DaCosta Byfield, S., et al. 2004. Mol. Pharmacol. 65, 744.